The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTclarke Regulatory News (CTO)

Share Price Information for Tclarke (CTO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 161.50
Bid: 161.00
Ask: 161.50
Change: 0.00 (0.00%)
Spread: 0.50 (0.311%)
Open: 161.50
High: 161.50
Low: 161.50
Prev. Close: 161.50
CTO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Shares

30 Apr 2015 07:20

RNS Number : 7760L
Clarke(T.) PLC
29 April 2015
 

T.CLARKE PLC EQUITY INCENTIVE PLAN - CONDITIONAL GRANT OF SHARES

On 29th April 2015, directors of the Company were granted conditional share awards over ordinary shares of 10p each in the capital of the Company ('shares') under the T.Clarke plc Equity Incentive Plan ('the Plan').

Details of the directors and the number of conditional share awards granted to them under the Plan are as follows:

Director

Number of conditional shares awarded

Mark Lawrence

90,000

Mike Crowder

90,000

Martin Walton

90,000

Danny Robson

90,000

 

No consideration was paid for the grant of the conditional share awards. The conditional share awards will normally vest on 29th April 2018, being the third anniversary of the date of grant, subject to continued employment with the Company and satisfaction of the earnings per share performance condition as set out below.

Annual growth in EPS above RPI*

Proportion of award vesting

Less than 3%

Nil

3%

25%

Between 3% and 10%

Between 25% and 100% on a straight line basis

Above 10%

100%

* Based on average underlying EPS for the three years ended 31 December 2014

The following conditional share awards and options granted on 1 May 2012 ('the 2012 awards') have lapsed as the minimum performance conditions were not met:

Director

Number of conditional shares lapsed

Number of options

lapsed

Mark Lawrence

115,000

59,000

Mike Crowder

115,000

59,000

Martin Walton

115,000

59,000

 

Following the grant of the conditional share awards and the lapse of the 2012 awards these directors hold the following interests in the issued share capital of the Company.

Director

Beneficial interest in the shares of the Company

% of the issued share capital of the Company

Total number of conditional share awards held

Total number of options

Mark Lawrence

26,750

0.06%

290,000

73,523

Mike Crowder

18,750

0.04%

290,000

73,523

Martin Walton

16,750

0.04%

290,000

73,523

Danny Robson

1,451,906

3.47%

90,000

-

 

 

For further information contact:

 

TClarke plc
Mark Lawrence
Martin Walton
Group Chief Executive
Finance Director
Tel: 020 7997 7400
Tel: 020 7997 7400

www.tclarke.co.uk

N+1 Singer (Financial Adviser and Broker)
Broker Profile
Sandy Fraser
Simon Courtenay
Tel: 020 7496 3000
Tel: 020 7448 3244
www.n1singer.com
www.broker-profile.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEAALNASASEAF
Date   Source Headline
26th Apr 20241:28 pmPRNForm 8.3 - TClarke Plc
26th Apr 202410:09 amRNSForm 8.5 (EPT/NON-RI) - TClarke PLC
25th Apr 20241:56 pmPRNForm 8.3 - TClarke Plc
25th Apr 202411:52 amRNSForm 8.3 - TClarke PLC
25th Apr 20249:18 amRNSForm 8 (OPD) - TClarke plc
24th Apr 20247:21 amRNSForm 8.5 (EPT/NON-RI)
22nd Apr 20242:58 pmPRNForm 8.3 - TClarke Plc
19th Apr 20241:21 pmPRNForm 8.3 - TClarke Plc
18th Apr 20243:29 pmRNSForm 8.3 - TClarke plc
18th Apr 20247:00 amRNSForm 8.1: Regent Acquisitions Limited
17th Apr 20243:29 pmRNSForm 8.3 - TClarke plc
17th Apr 20243:03 pmGNWForm 8.3 - [TCLARKE PLC - 16 04 2024] - (CGAML)
17th Apr 202412:57 pmEQSForm 8.3 - Apex Fundrock Limited : Form 8.3 - Opening Position Disclosure Re: Clarke (T.) PLC
17th Apr 20249:47 amRNSForm 8.5 (EPT/NON-RI)
16th Apr 20244:36 pmRNSWider Regent Group Interests in TClarke Shares
16th Apr 20247:00 amRNSRevised Dividend Timetable
16th Apr 20247:00 amRNSRecommended Cash Acquisition of TClarke plc
9th Apr 20241:41 pmRNSDirector/PDMR Shareholding
2nd Apr 20241:34 pmRNSTR-1 Notification of Holdings
27th Mar 20242:00 pmRNSDirector/PDMR Shareholding
15th Mar 20247:00 amRNSFinal Results
4th Jan 20247:00 amRNSBlock listing Interim Review
30th Nov 20237:00 amRNSTrading Update
24th Oct 202310:21 amRNSChange of Corporate Broker
27th Jul 20234:24 pmRNSTR-1: Notification of Change of Holding
24th Jul 20235:43 pmRNSUpdate on Admission
24th Jul 20233:32 pmRNSTR-1: Notification of Change of Holding
24th Jul 202311:48 amRNSResult of GM & Total Voting Rights
13th Jul 20231:23 pmRNSDirector/PDMR Shareholding
13th Jul 20237:00 amRNSHalf-year Report
6th Jul 20237:00 amRNSPlacing and Notice of GM
6th Jul 20237:00 amRNSTrading Statement
4th Jul 20237:00 amRNSBlock listing Interim Review
10th May 202311:31 amRNSResult of AGM
10th May 20237:00 amRNSAGM Trading Update
12th Apr 202311:15 amRNSNotice of AGM
27th Mar 202310:26 amRNSDirector/PDMR Shareholding
8th Mar 20237:00 amRNSTClarke - Preliminary Results
31st Jan 20237:00 amRNSNotice of Investor Presentation
26th Jan 20237:00 amRNSTrading Statement
4th Jan 202312:09 pmRNSBlock listing Interim Review
24th Nov 20227:00 amRNSTrading Statement
1st Nov 20225:13 pmRNSESOT Share Purchase
25th Oct 20222:14 pmRNSESOT Share Purchase
18th Jul 20227:00 amRNSInvestor Presentation
14th Jul 20227:00 amRNSHalf-year Report
5th Jul 202212:12 pmRNSBlock listing 6 Monthly Return
29th Jun 20227:00 amRNSNotice of Investor Presentation
23rd Jun 202210:45 amRNSNotice of Results
22nd Jun 20222:46 pmRNSChange of Auditor

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.